Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.020975
+0.000775 (3.84%)
At close: Sep 4, 2026
Bioxytran Market Cap
Bioxytran has a market cap or net worth of $2.41 million as of September 4, 2026. Its market cap has decreased by -63.96% in one year.
Market Cap
2.41M
Enterprise Value
3.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
ChartMarket Cap Chart
Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 2.41M, a decrease of -90.57%. That is a compound annual growth rate of -25.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 2.41M | -70.49% |
| Dec 31, 2025 | 8.15M | 4.49% |
| Dec 31, 2024 | 7.80M | -64.29% |
| Dec 29, 2023 | 21.85M | -63.00% |
| Dec 30, 2022 | 59.05M | 33.18% |
| Dec 31, 2021 | 44.34M | 89.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| International Stem Cell | 3.36M |
| CASI Pharmaceuticals | 3.15M |
| Affymax | 3.10M |
| Eastgate Biotech | 2.86M |
| AccuStem Sciences | 2.57M |
| Enzolytics | 2.42M |
| VitaSpring Biomedical | 2.30M |
| BioAtla | 2.17M |